IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza Reports Rise in First-Half Profits

12:13 AM MDT | July 22, 2010 | Deepti Ramesh

Lonza has recorded a 14.4% rise in first-half profits, to SF135 million ($130 million), compared to the year-ago period, and Ebitda increased by 3%, to SF309 million. Sales however decreased by 2%, to SF1.3 billion, mainly due to an expectedly weak first quarter in custom manufacturing, Lonza says. The Life Science Ingredients business recorded a 5.9% increase in sales in the first half, to SF536 million, compared with the year-ago period, and Ebit for the business increased by 17.4% to SF81 million. Volumes recovered in almost all end-markets except agchems...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa